Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants

被引：3
作者：
Hentzien, Maxime [1 ]
Owen, Andrew [2 ]
Strub-Wourgaft, Nathalie [3 ]
Perez-Casas, Carmen [4 ]
Troseid, Marius [5 ]
Calmy, Alexandra [1 ]
机构：
[1] Geneva Univ Hosp, Infect Dis Div, HIV AIDS Unit, Geneva, Switzerland
[2] Univ Liverpool, Ctr Excellence Long Acting Therapeut CELT, Liverpool, Merseyside, England
[3] Drugs Neglected Dis Initiat DNDi, Geneva, Switzerland
[4] Unitaid, Strategy, Geneva, Switzerland
[5] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway
来源：
FRONTIERS IN MICROBIOLOGY | 2022年 / 13卷
关键词：
COVID-19; direct-acting antivirals; immunocompromised; resistance; variant emergence; monoclonal antibodies; omicron; variants; OMICRON SUBVARIANTS;
D O I：
10.3389/fmicb.2022.998287
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
[41]   Analyzing the impact of SARS-CoV-2 variants on respiratory sound signals [J].
Bhattacharya, Debarpan ;
Dutta, Debottam ;
Sharma, Neeraj ;
Chetupalli, Srikanth Raj ;
Mote, Pravin ;
Ganapathy, Sriram ;
Chandrakiran, C. ;
Nori, Sahiti ;
Suhail, K. K. ;
Gonuguntla, Sadhana ;
Alagesan, Murali .
INTERSPEECH 2022, 2022, :2473-2477
[42]   Updated picture of SARS-CoV-2 variants and mutations [J].
Lippi, Giuseppe ;
Mattiuzzi, Camilla ;
Henry, Brandon M. .
DIAGNOSIS, 2022, 9 (01) :11-17
[43]   The Emerging Concern and Interest SARS-CoV-2 Variants [J].
Janik, Edyta ;
Niemcewicz, Marcin ;
Podogrocki, Marcin ;
Majsterek, Ireneusz ;
Bijak, Michal .
PATHOGENS, 2021, 10 (06)
[44]   Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity? [J].
Bauer, Lisa ;
van Riel, Debby .
MBIO, 2023, 14 (01)
[45]   Genomic diversity in SARS-CoV-2: Mutations and variants [J].
Romulo Aguilar-Gamboa, Franklin ;
Omar Suclupe-Campos, Danny ;
Arturo Vega-Fernandez, Jorge ;
Silva-Diaz, Heber .
REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO, 2021, 14 (04) :572-582
[46]   SARS-CoV-2 Variants: Mutations and Effective Changes [J].
Park, Gene ;
Hwang, Byeong Hee .
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2021, 26 (06) :859-870
[47]   A comparison of transmissibility of SARS-CoV-2 variants of concern [J].
Manathunga, S. S. ;
Abeyagunawardena, I. A. ;
Dharmaratne, S. D. .
VIROLOGY JOURNAL, 2023, 20 (01)
[48]   Lessons from SARS-CoV-2 and its variants [J].
Qin, Ziwen ;
Sun, Yan ;
Zhang, Jian ;
Zhou, Ling ;
Chen, Yujuan ;
Huang, Chuanjun .
MOLECULAR MEDICINE REPORTS, 2022, 26 (02)
[49]   Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study [J].
Schoning, Verena ;
Kern, Charlotte ;
Chaccour, Carlos ;
Hammann, Felix .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[50]   Functional landscape of SARS-CoV-2 cellular restriction [J].
Martin-Sancho, Laura ;
Lewinski, Mary K. ;
Pache, Lars ;
Stoneham, Charlotte A. ;
Yin, Xin ;
Becker, Mark E. ;
Pratt, Dexter ;
Churas, Christopher ;
Rosenthal, Sara B. ;
Liu, Sophie ;
Weston, Stuart ;
De Jesus, Paul D. ;
O'Neill, Alan M. ;
Gounder, Anshu P. ;
Nguyen, Courtney ;
Pu, Yuan ;
Curry, Heather M. ;
Oom, Aaron L. ;
Miorin, Lisa ;
Rodriguez-Frandsen, Ariel ;
Zheng, Fan ;
Wu, Chunxiang ;
Xiong, Yong ;
Urbanowski, Matthew ;
Shaw, Megan L. ;
Chang, Max W. ;
Benner, Christopher ;
Hope, Thomas J. ;
Frieman, Matthew B. ;
Garcia-Sastre, Adolfo ;
Ideker, Trey ;
Hultquist, Judd F. ;
Guatelli, John ;
Chanda, Sumit K. .
MOLECULAR CELL, 2021, 81 (12) :2656-+
12345